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The retromer complex is involved in the retrograde transport of the
CI-M6PR (cation-independent mannose 6-phosphate receptor)
from endosomes to the Golgi. It is a hetero-trimeric complex
composed of Vps26 (vacuolar sorting protein 26), Vps29 and
Vps35 proteins, which are conserved in eukaryote evolution.
Recently, elucidation of the crystal structure of Vps29 revealed
that Vps29 contains a metallo-phosphoesterase fold [Wang, Guo,
Liang, Fan, Zhu, Zang, Zhu, Li, Teng, Niu et al. (2005) J. Biol.
Chem. 280, 22962–22967; Collins, Skinner, Watson, Seaman and
Owen (2005) Nat. Struct. Mol. Biol. 12, 594–602]. We demon-
strate that recombinant hVps29 (human Vps29) displays in vitro
phosphatase activity towards a serine-phosphorylated peptide,
containing the acidic-cluster dileucine motif of the cytoplasmatic
tail of the CI-M6PR. Efficient dephosphorylation required the
additional presence of recombinant hVps26 and hVps35 proteins,
which interact with hVps29. Phosphatase activity of hVps29 was
greatly decreased by alanine substitutions of active-site residues
that are predicted to co-ordinate metal ions. Using inductively
coupled plasma MS, we demonstrate that recombinant hVps29
binds zinc. Moreover, hVps29-dependent phosphatase activity
is greatly reduced by non-specific and zinc-specific metal ion
chelators, which can be completely restored by addition of excess
ZnCl2. The binuclear Zn2+ centre and phosphate group were
modelled into the hVps29 catalytic site and pKa calculations
provided further insight into the molecular mechanisms of Vps29
phosphatase activity. We conclude that the retromer complex
displays Vps29-dependent in vitro phosphatase activity towards
a serinephosphorylated acidic-cluster dileucine motif that is in-
volved in endosomal trafficking of the CI-M6PR. The potential
significance of these findings with respect to regulation of
transport of cycling trans-Golgi network proteins is discussed.
Key words: cargo protein, cation-independent mannose 6-phos-
phate receptor (CI-M6PR), metallo-phosphoesterase, retromer,
trans-Golgi network, transport, vacuolar sorting protein 29
(Vps29).
INTRODUCTION
Eukaryotic cells contain several membrane-enclosed compart-
ments (organelles), each of which has a unique function that is
maintained by correct localization and retention of its resident
proteins. Eukaryote subcellular organization therefore requires
the existence of specific protein sorting and transport pathways
to and between various organelles. Genetic screens in Saccharo-
myces cerevisiae have identified several Vps (vacuolar sorting
protein) genes whose products are involved, directly or indirectly,
in anterograde or retrograde transport between the Golgi and
the lysosome-like vacuole [1–3]. Five of those gene products
form the retromer complex in yeast: Vps26, Vps29, Vps35, Vps5
and Vps17, which co-localize on early endosomes [4–6] and are
involved in retrograde endosome-to-Golgi transport [7].
In yeast, the Vps35 subunit interacts with the cargo protein
Vps10p, which is a type I transmembrane receptor that is involved
in the sorting of newly synthesized soluble vacuolar hydrolases,
such as CPY (carboxypeptidase Y), from the TGN (trans-Golgi
network) to the pre-vacuolar compartment. In the acidic environ-
ment, CPY dissociates from Vps10p and is then transported to the
vacuole [8–10]. In contrast, Vps10p is recognized by the Vps35
subunit of the retromer complex, which functions in the retrograde
transport of Vps10p from the pre-vacuolar compartment back to
the TGN [11]. In the TGN, Vps10 can carry out additional rounds
of enzyme delivery [9,10].
Orthologues of the yeast retromer proteins appear to be con-
served in nearly all eukaryotes, including mammals. Given the
role of the retromer complex in yeast, it is likely that the mam-
malian retromer functions in transport between the endosomes and
the TGN. Although yeast protein Vps10p does not have an ortho-
logue in mammals, mannose 6-phosphate receptors function in an
essentially similar manner. Indeed, retromer subunits co-localize
with the CI-M6PR (cation-independent mannose 6-phosphate
receptor) cargo protein [4,6] and hVps35 (human Vps35) directly
interacts with the CI-M6PR in the pre-lysosomal compartment
[4]. The CI-M6PR is involved in the sorting and transport of
newly synthesized lysosomal hydrolases that contain mannose
6-phosphate moieties on their N-glycan chains, which serve as
sorting signals for TGN-to-endosome transport [12]. One of the
triggers of this anterograde transport is the phosphorylation
of Ser2492 in the cytoplasmic tail of the CI-M6PR [13]. This
serine residue is part of the acidic-cluster dileucine sequence
DDSDEDLLHI, present in the C-terminus of the CI-M6PR. GGA
Abbreviations used: CI-M6PR, cation-independent mannose 6-phosphate receptor; CPY, carboxypeptidase Y; GFP, green fluorescent protein; GGA,
Golgi-associated γ-adaptin ear homology domain Arf (ADP-ribosylation factor)-interacting protein; GST, glutathione S-transferase; ICP-MS, inductively
coupled plasma MS; IPTG, isopropyl β-D-thiogalactoside; MCAC, metal chelation affinity chromatography; Ni-NTA, Ni2+-nitrilotriacetate; PBE, Poisson–
Boltzmann equation; ppb, parts per billion; PPP, phosphoprotein phosphatase; SNX, sorting nexin; TBS, Tris-buffered saline; TGN, trans-Golgi network;
TPEN, N,N,N′,N′-tetrakis(2-pyridylmethyl-)ethylene-diamine; Vps, vacuolar sorting protein; hVps, human Vps; VHS, Vps27, Hrs and Stam; WipKa, WHAT
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[Golgi-associated γ -adaptin ear homology domain Arf (ADP-
ribosylation factor)-interacting protein] proteins, which constitute
a family of clathrin coat adaptor proteins [14–18], bind with their
so-called VHS (Vps27, Hrs and Stam) domain to these acidic-
cluster dileucine sorting signals. GGA proteins transport the CI-
M6PR, in clathrin-coated vesicles, from the TGN to an endosomal
compartment en route to lysosomes [19–21]. Mutational analysis
reveals that Ser2492 itself is likely to play a role in GGA binding
[22] and GST (glutathione S-transferase) pull-down assays have
demonstrated that phosphorylation of this serine increases the
affinity of the CI-M6PR for the VHS domains of GGA1 and
GGA3 [23].
In the endosomal compartment, the CI-M6PR is able to bind
hVps35 [4]. hVps35 is not only the cargo recognition component,
but also the scaffold protein of the retromer complex, interacting
directly with hVps26 and hVps29 [5,24]. So far, the role of Vps29
and Vps26 is less clear; Vps29p probably assists Vps35p in cargo
binding and Vps26p promotes the interaction between Vps35p
and the SNXs (sorting nexins) Vps5p/Vps17p [25]. Vps5p binds
with its C-terminal domain to Vps17p to form a dimer [26] that
is able to form oligomeric structures, due to the self-assembly
activity of Vps5p [7,27]. This dimer is likely to have a structural
role in vesicle budding. In mammals, the Vps5p/Vps17p dimer
is replaced by its orthologue SNX1 and probably another SNX
protein [24]. In the case of the CI-M6PR, the co-operation of
all components of the retromer complex results in the retrograde
transport of the receptor from the endosome to the TGN, where it
can continue the transport of hydrolases [4,6].
Recently, two crystal structures of mammalian Vps29 have been
published [5,28], which revealed that Vps29 contains a metallo-
phosphoesterase fold. Metallo-phosphoesterases are enzymes
involved in the hydrolysis of phosphate esters [29] that contain two
metal ions in their active site. In the present study, we analyse the
function of Vps29 in more detail. Here, we tested the hypothesis
that hVps29 acts as a metallo-phosphoesterase for the CI-M6PR.
We demonstrate that hVps29 is a zinc-binding protein that acts
in vitro as a phosphatase on a synthetic phosphopeptide sequence,




hVps29 catalytic site point mutants were constructed by PCR,
using the pCIneo hVps29 mammalian expression vector (kindly
provided by C. R. Haft, National Institutes of Health, Bethesda,
MD, U.S.A.) as a template. For the hVps29 D8A mutation,
the following forward and reverse primers (5′–3′) were used:
CCACTTTGCCTTTCTCTCCA and GTTGCACCGGTGTGG-
GATGTGCAGAGCTCCTAATACCAA. The PCR product was
subcloned using EcoRI and AgeI sites. For all other mutations,
a two-step PCR strategy was used with the following forward and
reverse primers: CCACTTTGCCTTTCTCTCCA and ACTGCA-





CGC)CCTCTCACAATATG; for hVps29 H86A, AAAATTGG-
TCTGATCGCTGGACATCAAGTTAT and ATAACTTGATGT-
CCAGCCATCAGACCAATTTT; for hVps29 H117A, ATCTC-
GGGACACACAGCCAAATTTGAAGCATT and AATGCTTC-
AAATTTGGCTGTGTGTCCCGAGAT. PCR products were
subcloned using EcoRI and NotI sites. All mutations were verified
by sequencing.
YFP (yellow fluorescent protein) and GST fusion constructs
of the retromer subunits were constructed using the pEYFP-
C1 vector (Clontech) or pGEX4T1/3 vector (Amersham Bio-
sciences). For hVps26, the N-terminal Myc tag in the pCIneo
Myc hVps26 expression construct was replaced by a unique EcoRI
cloning site followed by an initiation codon, and the C-terminal
EcoRI site was replaced by a unique NotI restriction site. For
hVps29, a unique EcoRI cloning site was introduced at the 5′-end
of the pCIneo hVps29 Myc cDNA, while the C-terminal Myc tag
was replaced by a stop codon and a unique NotI cloning site. The
hVps26 and hVps29 cDNAs were cloned in frame into pEYFP-
C1 and pGEX4T3 using EcoRI and NotI/Bsp120I enzymes. For
hVps35, the Myc tag was removed from the pCIneo Myc hVps35
construct and the hVps35 cDNA was cloned in frame into the
pEYFP-C1 and pGEX4T1 vector using XhoI and NotI/Bsp120I
enzymes.
Myc–His fusion constructs of hVps26, hVps29 and hVps35
were constructed by introducing a KpnI restriction site before the
GST cDNA of the pGEX vectors and replacing the GST coding
sequence by a Myc–His coding sequence using linked primers.
Production of GST fusion proteins
GST fusion proteins were produced in the Escherichia coli XL-
2 Blue strain (Stratagene) containing the appropriate pGEX
plasmid. Cultures (0.5–5.0 litres) were grown to exponential
phase [A600 (absorbance) of 0.6–0.8] and protein expression was
induced by addition of IPTG (isopropyl β-D-thiogalactoside)
(Invitrogen) to 0.1 mM final concentration. After 1–3 h of induc-
tion, cells were harvested, rinsed with TBS (Tris-buffered saline)
(pH 7.4) and resuspended in TBS containing 1% Triton X-100,
100 µg/ml lysozyme and 10 µg/ml each of leupeptin, pepstatin
and aprotonin. The suspension was frozen at −20 ◦C for at least
16 h and subsequently thawed at 42 ◦C followed by sonication.
Lysates were cleared by centrifugation for 15 min at 12000 g and
then incubated with 0.5–3 ml of a 50% slurry of glutathione–
Sepharose beads (Sigma) for 2–4 h at 4 ◦C with rotation. The
glutathione–Sepharose beads were washed four times with TBS
(pH 7.4).
Production of Myc–His fusion proteins
Myc–His fusion proteins were produced in the E. coli XL-2
Blue strain containing the appropriate Myc–His plasmid. Cultures
of 200 ml were grown to exponential phase (A600 0.6–0.8) and
protein expression was induced by addition of IPTG (Invitrogen)
to 0.1 mM final concentration. After 4–5 h of induction, cells
were frozen at −20 ◦C for 16 h. Cells were thawed on ice and
resuspended in 4 ml of lysis buffer (10 mM imidazole, 150 mM
NaCl and 50 mM Tris/HCl, pH 8.0) and lysozyme was added to
a final concentration of 1 mM. The lysates were sonicated and
cleared by centrifugation for 15 min at 12000 g. Cleared lysates
were incubated with 1 ml of Ni-NTA (Ni2+-nitrilotriacetate) beads
(Qiagen) for 2–3 h at 4 ◦C with rotation. The Ni-NTA beads were
washed three times (10 mM imidazole, 300 mM NaCl and 50 mM
Tris/HCl, pH 8.0) and subsequently eluted with elution buffer
(250 mM imidazole, 300 mM NaCl and 50 mM Tris/HCl, pH 8.0)
and dialysed against water.
Pull-down assays
NIH3T3 cells were cultured on dishes coated with 0.1% gelatin
and grown at 37 ◦C in DMEM (Dulbecco’s modified Eagle’s
medium) supplemented with 10% (v/v) newborn calf serum.
pEYFP-C1 vector, Vps26, Vps29 and Vps35 YFP fusion con-
structs were transiently transfected into NIH3T3 cells using
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LipofectamineTM (Invitrogen) according to the manufacturer’s
instructions. After 22–24 h of transfection, the cells were lysed
in lysis buffer [150 mM NaCl, 25 mM Tris/HCl, pH 7.5, 5 mM
EDTA, pH 8.0, 1 mM Na3VO4, 1 mM NaF, 1 mM PMSF, 1 µg/ml
leupeptin, 1 µg/ml aprotinin and 1 µg/ml pepstatin] and the
lysates were transferred to Eppendorf tubes and centrifuged at
13000 g for 10 min at 4 ◦C in an Eppendorf centrifuge to remove
nuclei and cell debris. The cleared lysates were added to purified
GST fusion proteins of hVps26, hVps29 or hVps35 or to GST
alone that were bound to GSH–agarose beads and incubated for
at least 2 h at 4 ◦C. Unbound proteins were then removed by wash-
ing twice with lysis buffer and once with PBS.
In case of the pull-down experiments with the Myc–His fusion
proteins, Myc–His-tagged hVps29 and hVps35 were purified on
Ni-NTA beads, eluted and incubated for at least 2 h at 4 ◦C in the
presence of hVps26–GST immobilized on GSH–agarose beads.
Unbound proteins were then removed by washing three times with
TBS. Samples were then subjected to in vitro phosphatase assays
or Western-blot analysis.
For Western-blot analysis, the nitrocellulose membranes were
blocked for 1 h with 5% (w/v) BSA, incubated for 1 h at room
temperature (20 ◦C) with anti-GFP (green fluorescent protein)
antibody or anti-c-Myc (9E10) antibody (Santa Cruz Biotech-
nology), incubated for 30 min with appropriate peroxidase-linked
secondary antibodies and the immunocomplexes were visualized
with ECL® (enhanced chemiluminescence).
In vitro phosphatase assays
For in vitro phosphatase assays on GST fusion proteins alone,
GST fusion proteins were separated from their GST tags by
incubating the proteins with 10 units of thrombin (Amersham
Biosciences) in TBS (pH 7.4) in a total volume of 100 µl for at
least 16 h at room temperature. To each sample, 55 µg (1.1 mg/ml)
of serine-phosphorylated peptide SFHDDpSDEDLLHI (>95%
purity; Sigma-GenoSys) and 100 µl of serine/threonine assay
buffer (50 mM Tris/HCl, pH 7.0, and 100 µM CaCl2) (Upstate
Biotechnology) were added. The proteins were incubated with the
phosphopeptide at 37 ◦C for 30 min or 16 h. From each sample,
35 µl were added to 100 µl of Biomol Green (Biomol) in a 96-
well dish (Nunc). To analyse the amount of free phosphate, A630
was measured with a Wallac Multilabel counter 1420.
In case of the metal ion chelator experiment, GST
fusion proteins were incubated with 5 mM EDTA, EGTA or
TPEN [N,N,N ′,N ′-tetrakis(2-pyridylmethyl-)ethylene-diamine]
(Molecular Probes) for 15 min at room temperature and washed
three times with TBS prior to thrombin cleavage. For the
experiments in the presence of zinc and for the experiments using
Myc–His constructs, ZnCl2 was added to the serine/threonine
assay buffer at a final concentration of 1 mM.
The volume of the remaining supernatant of the samples was
reduced by means of a Speed Vac concentrator (type Svc100;
Savant), subjected to SDS/PAGE and proteins were visualized
using Coomassie Blue staining according to standard procedures.
ICP-MS (inductively coupled plasma MS)
GST alone and hVps29–GST fusion proteins were eluted from
glutathione–Sepharose beads by incubation with 5 mM GSH in
50 mM Tris/HCl (pH 8.0). The amount of protein in the super-
natant was measured using Bio-Rad Protein Assay Dye Reagent
concentrate (Bio-Rad). A small amount of the samples was
subjected to SDS/PAGE and proteins were visualized using
Coomassie Blue staining to confirm expression of the protein.
In order to perform accurate measurements, milligram quantities
of protein should be analysed. Series of equal amounts of GST
alone and hVps29–GST molecules were prepared by dilution with
5 mM GSH in 50 mM Tris/HCl (pH 8.0). HNO3 was added to
a final concentration of 2 M to destroy the proteins. The final
volume of the samples was 5 ml. Samples were centrifuged for
30 min at 5000 g and the supernatant was analysed by ICP-MS
(X Series ICP-MS; Thermo Electron) controlled with PlasmaLab
software v.2.3.0 according to the manufacturer’s instructions. The
measured amount of Mg, Ca, Cr, Fe, Mn, Ni, Co, Cu and Zn
metal ions in the samples was quantified in ppb (parts per billion)
using dilution series of CentiPur standard solutions (Merck).
The number of measured metal molecules was determined using
atomic mass numbers (zinc: 65.37 g/mol) and a ratio between
protein molecules and metal molecules was calculated.
Molecular modelling
Molecular modelling of the hVps29 active site was done
with YASARA (http://www.yasara.org) starting from the crystal
structure with two bound Mn2+ ions (PDB ID 1Z2W, [5]). The
highly similar structure of the human serine/threonine protein
phosphatase 5 [30] containing two Mn2+ ions plus a bound phos-
phate was structurally aligned using the SHEBA plugin [31], and
subsequently the phosphate co-ordinates were transferred to
Vps29. The Mn2+ ions were replaced by Zn2+ ions to match our
experimental findings. The phosphate was modelled as a mono-
anion with one hydrogen atom on O4 (the leaving group) and one
on O2, stabilized by the interaction with Asp62. The bridging water
molecule was turned into a hydroxide ion. Finally, the protein
side chains were energy minimized with the Yamber2 force field
to accommodate the changes [32].
pK a calculations
pKa calculations were carried out using the WIpKa (WHAT
IF pKa) calculation package as described earlier [33], with the
modification that the protein was described by a single dielectric
constant of 8. WIpKa relies on DelPhi II [34] to solve the linear
form of the PBE (Poisson–Boltzmann equation). The remaining
PBE parameters were set as follows: probe radius, 1.4 Å (1 Å =
0.1 nm); solvent dielectric, 80; final grid resolution, 0.25 Å/grid
point. Charges and radii were assigned using the OPLS force field
[35].
RESULTS
Retromer complex performs phosphoesterase activity on a
CI-M6PR-based substrate
Vesicular transport between various membrane-enclosed com-
partments is a fundamental characteristic of all eukaryotes. Most
proteins involved in fundamental vesicular trafficking processes
are evolutionarily conserved. Indeed, phylogenetic analysis (see
Supplementary Figures S1 and S2 at http://www.BiochemJ.org/
bj/398/bj3980399add.htm) demonstrates that Vps29 is found in
nearly all eukaryotes, including higher eukaryotes (metazoans,
plants and fungi) as well as protozoan groups such as
diplomonadida, apicomplexa, entamoebidae and kinetoplastidae.
Interestingly, BLAST searches also reveal the similarity of
eukaryote Vps29 proteins to hypothetical archaeal proteins with
(putative) phosphoesterase activity (e.g. MJ0936), even though
archaea do not contain organelles. Vps29 shows extremely high
sequence conservation among vertebrates; only 14 out of the 182
amino acids show sequence variations, most of which are con-
servative substitutions (Supplementary Figure S3 at http://
www.BiochemJ.org/bj/398/bj3980399add.htm).
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Figure 1 Interaction of hVps29 with hVps26 and hVps35 in vitro
(A) GST fusion proteins were used as an affinity matrix for hVps26, hVps29 and hVps35 YFP fusion proteins present in the lysates of transiently transfected NIH3T3 cells. Affinity precipitated proteins
were visualized by Western-blot analysis with anti-GFP antibodies (v: vector; 26: Vps26; 29: Vps29; and 35: Vps35). (B) Western blot of whole cell lysate samples of NIH3T3 cells transfected with
the YFP fusion constructs, detected with anti-GFP antibodies. (C) Coomassie Blue staining of the GST fusion constructs used for the pull-down assay.
Recent crystallographic studies demonstrate that Vps29 be-
longs to the PPP (phosphoprotein phosphatase) family of
calcineurin-like metallo-phosphatases, although Vps29 enzy-
matic activity has yet to be established [5,28]. This family is not
only found in eukaryotes, but also in archaea and prokaryotes [36].
The crystal structures of members of this family are characterized
by a double β-sandwich, surrounded by α-helices (reviewed in
[37]). Metallo-phosphoesterases contain two metal ions in their
catalytic site, which stabilize a highly reactive hydroxyl ion at
physiological pH that is in position for nucleophilic attack of
the phosphoester bond. The positively charged metal ions can
also serve as an electrophilic catalyst and stabilize developing
negative charge(s) of the metal–PO4 transition state. The oxy-
anion of the substrate leaving group is usually protonated by a
catalytic histidine residue that forms a catalytic dyad with a neigh-
bouring aspartic acid residue, which provides the histidine resi-
due with acidic properties. Efficient regeneration of catalytic
hydroxyl ions is required for the active status of the enzyme,
which has been proposed to occur through a network of hydrogen-
bonded water molecules in the active site, leading to protonation
of a surrounding basic histidine residue and release of the proton
into bulk solvent [29].
The metal-co-ordinating and catalytically important residues,
mostly aspartic acid and histidine residues, are conserved among
metallo-phosphoesterase family members and are located within
five conserved motifs (I through V) (see Supplementary Figure
S3 at http://www.BiochemJ.org/bj/398/bj3980399add.htm) in
loops connecting the core α and β secondary structure ele-
ments, i.e. DXH(X)∼25 GDXXD(X)∼25 GNH[D/E] (motifs I–
III [38,39]) and GH(X)∼50 GHX[H/X] (motifs IV–V [40]).
The corresponding motifs of hVps29 start with Asp8, Gly38,
Gly61, Gly87 and Gly114 respectively (see Supplementary Fig-
ure S3 at http://www.BiochemJ.org/bj/398/bj3980399add.htm).
Interestingly, hVps29 shows three unique features that distin-
guish hVps29 from other metallo-phosphoesterases with a
known crystal structure (see Supplementary Figure S3 at http://
www.BiochemJ.org/bj/398/bj3980399add.htm). First, an aspartic
acid residue is normally found in the position of Asn39 (motif II).
Secondly, an asparagine is normally found in the position of
Asp62 (motif III). Thirdly, the catalytic histidine residue (motif
III), which serves as a proton donor for the leaving group, is
replaced by Phe63.
In order to determine whether the retromer complex contains
phosphatase activity, we first assessed whether the retromer
subunits interact using in vitro affinity precipitations (Figure 1A).
Mammalian expressed YFP fusion proteins (Figure 1B) were in-
cubated for 3 h at 4 ◦C with GST fusion proteins of hVps26,
hVps29 and hVps35 (Figure 1C). As seen in Figure 1(A),
hVps26–GST and hVps35–GST interact with Vps29–YFP but not
with YFP alone, whereas hVps29–GST interacts with hVps26–
YFP as well as with hVps35–YFP and not with YFP alone. Thus,
consistent with earlier reports [5], interaction between retromer
subunits can be demonstrated by in vitro affinity precipitation.
To determine whether hVps29 is an active metallo-phos-
phoesterase, we assayed recombinant hVps29 for in vitro
phosphatase activity. GST fusion proteins of hVps26, hVps29
and hVps35 were separately produced in E. coli and the respective
recombinant proteins were separated from their GST tags using
the thrombin cleavage site (Figure 2A). Given that (i) the mam-
malian retromer complex functions in the retrograde transport of
cycling TGN proteins, (ii) retromer subunits co-localize with the
CI-M6PR, and (iii) mammalian Vps35 directly interacts with
the CI-M6PR in the pre-lysosomal compartment [4,6], we used the
serine-phosphorylated peptide SFHDDpSDEDLLHI, containing
the acidic-cluster dileucine motif of the CI-M6PR C-terminal
tail, as an in vitro phosphatase substrate. Recombinant hVps26,
hVps29 or hVps35 or a mixture of non-stoichiometric amounts
of all three proteins was incubated (30 min and 16 h) with the
phosphopeptide at 37 ◦C. The amount of free phosphate, which
correlates with the phosphatase activity, was measured in each
sample after 30 min and after 16 h. Figure 2(B) shows that there
was no dephosphorylation activity detectable after 30 min for the
individual retromer proteins. Interestingly, only hVps29 showed
phosphatase activity on its own after 16 h of incubation at
37 ◦C. The detected amount of free phosphate was considerably
higher than the amount of free phosphate measured in the
vector control, or measured in hVps26 and hVps35. Importantly,
when the three retromer subunits were added simultaneously to
the phosphatase reaction, the phosphatase activity was already
detectable after 30 min of incubation at 37 ◦C. Protein expression
in the phosphatase reaction was confirmed by Coomassie Brilliant
Blue staining of the remaining supernatant of the samples used in
the assay (Figure 2C).
To further confirm phosphatase activity of the retromer subunits
as a complex, we used GST–Vps26 or GST alone coupled
with GSH–agarose beads as an affinity matrix for recombinant
Myc–His-tagged Vps29 and Vps35 proteins that were purified by
MCAC (metal chelation affinity chromatography) from bacterial
c© 2006 Biochemical Society
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Figure 2 Phosphatase activity of hVps29 on a CI-M6PR phosphopeptide
(A) Coomassie Blue staining of recombinantly expressed GST fusion proteins of vector (26 kDa),
hVps26 (36 kDa), hVps29 (20 kDa) and hVps35 (87 kDa) before and after thrombin cleavage.
(B) Detected amounts of free phosphate in an in vitro phosphatase assay on the
SFHDDpSDEDLLHI phosphopeptide using recombinantly expressed vector, hVps26, hVps29
or hVps35 or a mixture of these three proteins. Levels of free phosphate were determined after
30 min and after 16 h of incubation at 37◦C. (C) Coomassie Blue staining of the remaining
supernatant of the protein samples used for the in vitro phosphatase assay.
lysates. Consistent with the results shown in Figure 1, both
Myc–His-tagged Vps29 and Vps35 were detected by anti-Myc
Western blotting in GST–Vps26 affinity precipitates (Figure 3A),
indicating that retromer subunits were able to form a complex
in vitro. To determine whether these complexes contained phos-
phatase activity, the GST–Vps26 affinity precipitates containing
Myc–His-tagged Vps29 and Vps35 were used for an in vitro
phosphatase assay using the serine-phosphorylated SFHD-
DpSDEDLLHI peptide as a substrate (Figure 3B). Protein
expression in the phosphatase assay was confirmed by Coomassie
Blue staining of the remaining supernatant of the samples
used in the assay (Figure 3C). As shown in Figure 3(B),
affinity precipitates of GST–Vps26 but not GST alone contained
phosphatase activity towards the CI-M6PR substrate peptide.
The amount of phosphatase activity detected in the GST–
Vps26 affinity precipitates was consistently much lower than
observed when phosphatase activity was assayed on a mixture of
GSH–agarose-bound GST–Vps26, GST–Vps29 and GST–Vps35
protein following thrombin cleavage (Figure 3B, third bar). It
is likely that the reduced phosphatase activity detected in the
GST–Vps26 affinity precipitates is due to the presence of reduced
amounts of Myc–His-tagged Vps29 and Vps35 proteins, since
we were unable to detect Myc–His-tagged Vps29 and Vps35
in GST–Vps26 affinity precipitates by Coomassie Blue staining
(Figure 3C).
Collectively, the results shown in Figures 1–3 demonstrate that
(i) Vps26, Vps29 and Vps35 can co-precipitate in vitro, (ii) Vps29
alone but not Vps26 or Vps35 contains phosphatase activity,
(iii) Vps29 phosphatase activity is greatly enhanced by the
additional presence of Vps26 and Vps35 retromer subunits, and
(iv) GST–Vps26 affinity matrices acquire phosphatase activity
following affinity precipitation of – and complex formation
with – Myc–His-tagged Vps29 and Vps35 retromer subunits.
We conclude that the retromer complex contains in vitro phos-
phatase activity towards the serine-phosphorylated peptide
SFHDDpSDEDLLHI containing the acidic-cluster dileucine
motif of the CI-M6PR cytoplasmic tail.
Catalytic-site mutations of hVps29 inhibit its phosphoesterase
activity
To analyse the phosphoesterase activity of hVps29 in more detail,
we generated a model based on the published mVps29 struc-
ture [5] of the hVps29 catalytic site containing a binuclear
Zn2+ centre (see below) and a bound phosphate (Figure 4). If
the substrate phosphopeptide is bound, both metal ions are co-
ordinated by six ligands; metal 1 is co-ordinated by Asp8, His10
(motif I), Asn39 (motif II), His117 (motif V), a bridging hydroxide-
ion (W1), and O1 of the bound phosphate, whereas metal 2 is co-
ordinated by Asn39 (motif II), Asp62 (motif III), His86 (motif IV),
His115 (motif V), W1 and O2 of the bound phosphate (Figure 4).
In this model, the phosphate group is further positioned by the
interaction of the absolutely conserved Arg14 with the leaving
group oxygen (O4) of the phosphorylated peptide.
To study the role of these catalytic-site residues in the
phosphoesterase reaction, we constructed D8A, N39A, D62A,
H86A and H117A mutants as well as a D8A/H86A double
mutant of hVps29. GST alone or GST fusion proteins of hVps26,
hVps35, wild-type and mutant hVps29 were produced in E. coli
and the respective recombinant proteins were separated from
their GST tags using thrombin cleavage. Equal amounts of
hVps26 and hVps35 proteins were added to samples containing
GST alone, wild-type hVps29 or mutant hVps29. Bacterial
expression of several catalytic-site mutants was less efficient
when compared with the wild-type hVps29 protein, as previously
reported by Collins et al. [5]. To compare phosphatase activity
of different amounts of mutant hVps29 protein with wild-type
hVps29 protein, we used a dilution series of the wild-type pro-
tein. Recombinant protein expression of each of the mutant
constructs was within the range of the dilution series of the wild-
type hVps29 protein (Figure 5B). At all concentrations tested,
wild-type hVps29 displayed robust in vitro phosphatase activity
towards the phosphorylated SFHDDpSDEDLLHI substrate after
30 min (Figure 5A).
Each of the catalytic-site mutants showed greatly reduced
phosphatase activity towards the CI-M6PR serine-phosphorylated
peptide (Figure 5A), demonstrating that phosphatase activity of
the retromer complex can be blocked by introduction of mutations
in the catalytic site of hVps29. These findings directly demonstrate
that hVps29 is a phosphatase. Based on the crystal structure
of other metallo-phosphatases, we conclude that mutations in
Asp8, Asn39, Asp62, His86 and His117 disrupt binding of one of the
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Figure 3 Phosphatase assay on affinity-precipitated retromer complex
(A) Western blot with anti-c-Myc antibody. Lanes 1–3, expression of purified Myc–His constructs following MCAC with Ni-NTA beads. Lanes 4–5, hVps26–GST affinity precipitation following
incubation with Myc–His vector or with purified Myc–His hVps29 and hVps35 protein (v: vector; 29: Vps29; and 35: Vps35). (B) Detected amounts of free phosphate in an in vitro phosphatase assay
on the SFHDDpSDEDLLHI phosphopeptide using GST vector (bar 1), an affinity precipitation of Vps26–GST containing Vps29 and Vps35 Myc–His fusion proteins (bar 2) or as a positive control,
a mixture of hVps26, hVps29 and hVps35 proteins (bar 3), as used in Figure 2. Levels of free phosphate were determined after 30 min of incubation. (C) Coomassie Blue staining of the remaining
supernatant of the protein samples used for the in vitro phosphatase assay.
Figure 4 Molecular model of the hVps29 active site
The catalytic site of hVps29 showing two Zn2+ ions, the co-ordinating amino acid side chains
and a bound phosphate. The hydroxide ion bridging the two metal ions is labelled ‘W1’ and is
hydrogen-bonded to the backbone oxygen of His115. Only polar hydrogen atoms are shown. The
serine residue of the substrate peptide has been omitted, but should be connected to the now
protonated phosphate oxygen. The image was created with YASARA (http://www.yasara.org).
metal ions to the catalytic site of hVps29, leading to ablation of
enzymatic activity.
Recombinant hVps29 is a zinc-binding protein
The geometry of the catalytic site of hVps29 best resembles that
of the Mn2+/Mn2+ binuclear metal centre of MRE11, a 3′–5′
endonuclease from Pyrococcus furiosus (PDB code 1II7) [41],
so we hypothesized that Vps29 bound metal ions, possibly Mn2+,
although other metal ions (Cr, Fe, Co, Ni, Cu and Zn) are known
to be present in the active site of metallo-phosphatases as well. To
identify metal ions bound to native hVps29, we performed ICP-
Figure 5 Inhibition of the phosphatase activity of hVps29 by catalytic-site
mutants
(A) Detected amounts of free phosphate in an in vitro phosphatase assay on the
SFHDDpSDEDLLHI phosphopeptide using recombinantly expressed hVps26 and hVps35 in
combination with vector, wild-type hVps29 in increasing concentrations, as indicated by the
elongated chevron, or hVps29 mutants D8A, N39A, D62A, H86A, H117A or D8A/H86A. Levels
of free phosphate were determined after 30 min of incubation. (B) Coomassie Blue staining of
the remaining supernatant of the protein samples used for the in vitro phosphatase assay.
MS on the hVps29–GST fusion protein and on GST alone (see
the Materials and methods section). Figure 6(A) shows that the
amount of zinc present in samples containing hVps29–GST was
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Figure 6 Detected amounts of zinc ions in hVps29–GST by ICP-MS
(A) Binding of zinc ions (in ppb) to increasing amounts of recombinantly expressed hVps29–GST
fusion protein or GST alone. (B) Linear increase in the amount of zinc induced by increasing
amounts of recombinantly expressed hVps29–GST fusion protein corrected for binding to GST
alone. The slope of the line indicates the molar ratio of hVps29–GST/zinc. (C) Coomassie Blue
staining of a small amount of the recombinantly expressed proteins used in the ICP-MS analysis.
The protein amount was measured by photospectrometric analysis (results not shown), and also
by comparison with BSA levels.
much higher than that in the samples containing GST alone. This
difference was not detected for Mn, Cr, Fe, Co, Ni or Cu (Table 1)
or any other element (results not shown). The amount of zinc
in samples containing hVps29–GST increased linearly with the
amount of hVps29–GST analysed (Figure 6B), correlating with
a relatively constant calculated molar ratio between hVps29–
GST and zinc of approx. 1:0.3. Although a molar ratio of 1:2
is expected, there may be an overestimation of the presence of
hVps29–GST in the measured samples, due to the presence of a
Table 1 Detected amounts of metal ions in hVps29–GST by ICP-MS
Samples of recombinantly expressed hVps29–GST fusion protein and GST alone with an
increasing amount of molecules were analysed by ICP-MS. Depicted are the amounts in ppb of
those metal ions that were the best candidates for binding to hVps29–GST.
1015 × GST Metal ions in ppb
Metal ion protein molecules. . . 2.58 6.45 12.9 19.4
Mg
GST 0.757 0.058 0.436 0.681
Vps29 0.978 2.372 0.034 1.125
Ca
GST 111.7 62.8 81.7 122.1
Vps29 116.2 217.4 51.1 77.5
Cr
GST 0.337 0.212 0 0.549
Vps29 0 0.222 0 0.164
Fe
GST 20.56 0 0 102.8
Vps29 0 0 0 0.9
Mn
GST 0.212 0 0 1.268
Vps29 0 0 0 0.02
Ni
GST 0.499 0.134 0 1.548
Vps29 0 0.183 0 0.002
Co
GST 0.036 0.006 0.006 0.021
Vps29 0.006 0.013 0.025 0.036
Cu
GST 0.515 0 0 0.346
Vps29 0.062 1.458 0.181 0.656
Zn
GST 3.229 2.682 1.933 0.886
Vps29 25.08 52.58 84.08 135.3
small amount of GST alone and other contaminating proteins
(Figure 6C). Moreover, it is possible that a fraction of the hVps29–
GST fusion proteins, produced in E. coli, has an incorrect folding
or is not able to acquire zinc molecules co- or post-translationally.
Nevertheless, we conclude that recombinant hVps29 is a
zinc-binding phosphoesterase. Mutant hVps29 proteins could not
be analysed by ICP-MS, due to their reduced expression levels.
Inhibition of the phosphatase activity by metal ion chelators
To investigate the role of the presence of metal ions in the
catalytic site of hVps29 on its phosphoesterase activity, we
performed phosphatase assays after treatment with several metal
ion chelators. Treatment of the recombinantly expressed retromer
proteins with non-specific metal ion chelators such as EDTA
or EGTA prior to thrombin cleavage, resulted in an 80%
reduction of the enzymatic activity of the retromer complex on
the SFHDDpSDEDLLHI phosphorylated peptide (Figure 7A).
More interestingly, pretreatment of the recombinantly expressed
retromer proteins with the zinc-specific chelator TPEN led
to a reduction of the phosphatase activity by approx. 50%
(Figure 7A). Re-addition of ZnCl2 restored the phosphatase
activity of the TPEN-treated samples to the level of untreated
wild-type hVps29 (Figure 7A). Addition of ZnCl2 without TPEN
treatment did not increase the phosphatase activity of the retromer
complex on the SFHDDpSDEDLLHI phosphorylated peptide.
Protein expression in the phosphatase assay was confirmed by
Coomassie Blue staining of the remaining supernatant of the
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Figure 7 Inhibition of the phosphatase activity of hVps29 by metal ion chelators
(A) Detected amounts of free phosphate in an in vitro phosphatase assay on the SFHDDpSDEDLLHI phosphopeptide using recombinantly expressed hVps26 and hVps35 in combination with vector
as a control or wild-type hVps29. Samples were treated with 5 mM of the indicated metal ion chelators prior to thrombin cleavage. When indicated, ZnCl2 was added to the reaction mixture to a final
concentration of 1 mM. Levels of free phosphate were determined after 30 min of incubation at 37◦C. (B) Coomassie Blue staining of the remaining supernatant of the protein samples used for the
in vitro phosphatase assay.
Figure 8 Effect of the Asn39/Asp62 pair on the phosphatase activity
(A) Detected amounts of free phosphate in an in vitro phosphatase assay on the SFHDDpSDEDLLHI phosphopeptide using recombinantly expressed hVps26 and hVps35 in combination with vector,
wild-type hVps29 in increasing concentrations, as indicated by the elongated chevron, and hVps29 mutants N39A, N39D, D62A, D62N and N39D/D62N. Levels of free phosphate were determined
after 30 min of incubation at 37◦C. (B) Coomassie Blue staining of the remaining supernatant of the protein samples used for the in vitro phosphatase assay.
samples used in the assay (Figure 7B). We conclude that hVps29
contains zinc ions that are essential for phosphatase activity of the
retromer complex.
Functional significance of the Asn39/Asp62 switch in hVps29
As previously discussed in the subsection ‘Retromer complex
performs phosphoesterase activity on a CI-M6PR-based sub-
strate’ in the Results section, Vps29 is unique among PPP-
type metallo-phosphatases because of the presence of Asn39
(instead of Asp), Asp62 (instead of Asn) and Phe63 (instead of
a catalytic histidine). To determine the functional significance
of the Asn39/Asp62 switch for hVps29 phosphatase activity, we in-
troduced the N39D, D62N as well as a N39D/D62N double
mutation into pGEX4T3–hVps29 and evaluated the phosphatase
activity of these mutants. Recombinant protein expression of
each of the mutant constructs was within the range of the
dilution series of the wild-type hVps29 protein (Figure 8B). As
expected, the N39D mutation had no effect on the phosphatase
activity (Figure 8A). Interestingly however, the D62N mutation
blocked hVps29 phosphatase activity, which was also seen for the
N39D/D62N double mutant. These results indicate that hVps29
Asn39 can be replaced by an aspartic acid residue because both
side chains can contribute a metal bridging oxygen at this position.
In contrast, Asp62 cannot be replaced by an asparagine residue,
indicating that both oxygens in the carboxy group are functionally
important in hVps29. This is surprising, as the amino group of
asparagine would be ideally suited to bind the phosphate O2
oxygen, an interaction found in all available X-ray structures of
ligated metallo-phosphatases.
Since Vps29 lacks the catalytic histidine residue in motif III,
we considered the possibility that Asp62 might help to replace it.
To investigate whether Asp62 could take the role of the general
acid and neutralize the oxy-anion of the leaving group, we
performed pKa calculations for the active-site residues and found
that protonation of Asp62 is highly unlikely; owing to the presence
of the metal ions and the strong hydrogen bond between Asn39
and Asp62, the predicted pKa of Asp62 is below zero. The same is
true for the histidine residues close by, which are all involved in
metal binding. A more plausible explanation for the importance of
Asp62 is depicted in Figure 4: Asp62 may help to stabilize a proton
on the phosphate O2 atom by forming a hydrogen bond. In
the trigonal bipyramidal transition state of the reaction [30], the
proton could come sufficiently close to reach the leaving group
directly, or alternatively jump via an associated water molecule.
Another possible role of Asp62 might involve protein binding, and
its importance is best illustrated by the conservation of a charged
residue in this position among several plant and fungal species
(see Supplementary Figure S3 at http://www.BiochemJ.org/
bj/398/bj3980399add.htm). Although the complete function of
hVps29 Asp62 remains unclear, its importance for the catalytic
activity of hVps29 is clearly demonstrated.
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DISCUSSION
hVps29 functions as a phosphoesterase in vitro
In the present study, we have characterized the function of the
retromer component hVps29. Recently published crystal struc-
tures of Vps29 by Wang et al. [28] and Collins et al. [5] indi-
cate that Vps29 contains a metallo-phosphoesterase fold, but
these authors could not experimentally show its phosphoesterase
activity. Here, we demonstrate in vitro phosphatase activity
for the hVps29-containing retromer complex towards a serine-
phosphorylated peptide SFHDDpSDEDLLHI substrate, contain-
ing the acidic-cluster dileucine motif of the CI-M6PR tail. There
was no phosphatase activity measured towards the threonine-
phosphorylated peptide KRpTIRR, which can be dephosphory-
lated by PP2A (protein phosphatase 2A), demonstrating substrate
specificity for the hVps29-containing retromer complex (results
not shown).
The discrepancy between the studies with respect to mam-
malian Vps29 phosphatase activity may be explained by several
differences in the experimental conditions. First, we observed
that the phosphatase activity of hVps29 alone was only detectable
after prolonged overnight incubation. Moreover, we demonstrated
by affinity precipitations that hVps29 interacts with the other
retromer subunits, consistent with Collins et al. [5], and that the
addition of hVps26 and hVps35 to the reaction mixture greatly
enhanced the phosphatase activity. These results indicate that the
retromer complex functions as a holo-enzyme complex. Indeed,
using hVps26–GST as a bait, we were able to affinity precipitate
the hVps29 and hVps35 retromer subunits, which resulted in
acquisition of phosphatase activity. The requirement for the other
retromer subunits may be due to the involvement of Vps26 and/or
Vps35 in (i) substrate recognition [4,6,8–10], (ii) contributions
of active-site residues (see below), and/or (iii) assembly, folding
or stability of the active retromer complex [10,20,25]. Vps35p is
very unstable when either Vps29 or Vps26 is mutated or deleted
[10,20]. Moreover, anti-Vps26 siRNAs treatment of mammalian
cell lines does not only lead to depletion of endogenous Vps26,
but also to depletion of Vps29 and Vps35 [4,6], indicating that
all retromer subunits must be present to form a stable complex.
Secondly, we avoided any influence of the GST protein on the
assembly and activity of the retromer complex. We used recom-
binant proteins only (i) after the recombinant retromer protein was
cleaved from the GST moiety by thrombin or (ii) after replacing
the GST moiety by the smaller Myc–His tag.
Thirdly, we demonstrated hVps29 phosphatase activity towards
the serine-phosphorylated peptide SFHDDpSDEDLLHI sub-
strate. Collins et al. [5] could not detect phosphatase activity
of hVps29 towards PNPP (p-nitrophenyl phosphate)-based sub-
strates and several soluble phosphatidylinositol phosphates.
hVps29 is a zinc-binding protein
Apart from the Asn39/Asp62 switch, the catalytic site of hVps29
best resembles that of the MRE11 endonuclease which contains
a binuclear Mn2+ centre [41]. Collins et al. [5] and Wang et al.
[28] soaked mVps29 crystals in MnSO4 and observed that the
mVps29 catalytic site can bind bivalent metal ions. However,
these studies did not identify the metal ions bound to native
Vps29 or the metal ions required for enzymatic activity. ICP-MS
analysis revealed that native hVps29 contains Zn2+. We demon-
strated that zinc binding is involved in the enzymatic activity of
hVps29 by performing phosphatase assays with the specific zinc
metal chelator TPEN, which reduces the phosphatase activity.
Moreover, we demonstrated that addition of ZnCl2 after TPEN
treatment restores the phosphatase activity.
More than 300 enzymes, covering all six classes of enzymes,
have been discovered which require zinc ions for their activity
[42]. Moreover, zinc is the most common metal used in metallo-
enzymes that catalyse hydrolysis or hydration reactions [29].
Importantly, other PPP-type phosphatases, including purple acid
phosphatase (PDB code 4KBP) [43], calcineurin (1AUI) [44]
and 5′ nucleotidase (1USH) [45] also contain Zn2+ ions in their
catalytic sites.
Implications for the catalytic mechanism
Even though we were able to demonstrate phosphatase activity for
the retromer complex, many questions regarding the enzymatic
reaction remain. First, the identity of the nucleophile that
attacks the phosphate is unclear. The active site of metallo-
phosphoesterases contains water molecules, one of which is in-
variably involved in the co-ordination of both metal ions in a
µ-hydroxo bridge (W1) (Figure 4). Frequently, a second water
molecule (W2) is detected bound to metal 1. Which of these water
molecules acts as the nucleophile during catalysis is a question
of debate [46]. In general, the pKa of W1 is sufficiently low to
be deprotonated and to become a hydroxide ion. Opposite to the
leaving group, W1 is also in an ideal position for in-line attack of
the phosphorus atom. However, as W1 binding to both metal ions
reduces its nucleophilicity, it has been suggested that metal
1-bound W2 is the nucleophile that attacks the phosphoester
bond [40]. However, this mechanism was proposed for purple
acid phosphatase co-ordinating two different metal ions, Zn2+
and Fe3+ [43]. Binding of trivalent Fe3+ to W2 can lower the
pKa of W2 sufficiently such that W2 exists as a hydroxide ion at
physiological pH. In contrast, bivalent Zn2+ ions cannot lower the
pKa of terminally ligated water molecule sufficiently to create a
hydroxide ion by itself at physiological pH [47]. In that case,
a general base may be required to further lower the pKa of
W2. Although we cannot exclude that W2 (if existing) is the
nucleophilic hydroxide molecule, we favour the hypothesis that
the hydroxide ion W1 is the one that is involved in the nucleophilic
attack, as discussed in detail by Swingle et al. [30].
The second question that remains concerns the identity of the
proton donor that protonates the oxy-anion of the leaving group.
Unlike most other eukaryotic PPP-type metallo-phosphatases,
Vps29 lacks a catalytic histidine residue in motif III. Building on
their negative results with respect to Vps29 phosphatase activity,
Collins et al. [5] suggested that another cofactor (such as Vps26
or Vps35) might contribute a catalytic histidine to the Vps29
active site. Based on current (draft) whole genome sequencing
programmes, both Vps26 and Vps35 retromer proteins contain
histidine residues that are nearly absolutely conserved among
all eukaryotes and could be candidates for the delivery of the
missing histidine (results not shown). However, the low but
measurable in vitro phosphatase activity of hVps29 in the absence
of hVps26 and hVps35 seems inconsistent with such a model. In
addition, molecular modelling suggests that there is very little
space to insert a histidine in the gap that is created by the
outward movement of Phe63 that occurs upon metal binding (E.
Krieger, unpublished work). It should be noted that we cannot
exclude the possibility that conformational changes occur in
the Vps29 catalytic site upon assembly of the holo-retromer
complex. Importantly, despite lacking a catalytic histidine residue
in motif III, the archaeal protein MJ0936 is also an active metallo-
phosphoesterase [48], indicating that a catalytic histidine is not
absolutely required for phosphoesterase activity. Yet another
possibility that needs to be considered is that there is no specific
proton donor for the leaving group, and that the leaving group
slowly retrieves a proton from bulk water. Finally, it is important to
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Figure 9 Model of phosphate-dependent transport of the CI-M6PR
The CI-M6PR binds cathepsin D in the TGN. Binding of GGAs to the phosphorylated CI-M6PR
causes the transport of the ligand–receptor complex to the endosome. In the endosome, the
ligand dissociates from the receptor and after binding to Vps35, Vps29 is able to dephosphorylate
the receptor. The retromer recycles the CI-M6PR to the TGN.
realize that the pKa calculations must be interpreted with caution:
they were performed on hVps29 alone, in the presence of the
binuclear Zn2+ centre and in the presence or absence of bound
tri-anionic phosphate, even though it is clear that the enzymatic
activity of hVps29 is greatly enhanced when bound to hVps26 and
hVps35. Given that mVps35 binds close to the mVps29 active site
[5], it is conceivable that the immediate environment of the Vps29
active site, i.e. the charge distribution, and thus the predicted
pKa values, is changed upon incorporation of Vps29 in the holo
retromer complex. Crystallization of the holo-retromer complex
will probably be necessary to answer some of these questions.
A third question that remains concerns the evolutionary conser-
vation of Vps29 enzymatic function. Although metal-co-ordin-
ating catalytic-site residues of Vps29 are highly conserved
in most metazoans, there are multiple substitutions in those
residues among pseudo-coelomate nematodes, and various fungal
and protozoan species (see Supplementary Figure S3 at http://
www.BiochemJ.org/bj/398/bj3980399add.htm). It remains to be
demonstrated whether the retromer complex displays phos-
phatase activity in yeast and other species or whether there
may be functional differences in the retromer complex among
species.
Trafficking of the CI-M6PR depends on the phosphorylation status
of the receptor
We demonstrate that the retromer component hVps29 interacts
with hVps26 and hVps35 retromer subunits and functions
in vitro as a phosphoesterase for a phosphopeptide based on the
sequence of the CI-M6PR tail. A working model for the in vivo
role of hVps29-mediated dephosphorylation of the acidic-cluster
dileucine motif of the CI-M6PR is presented in Figure 9. After
binding to mannose 6-phosphate-tagged lysosomal hydrolases
in the TGN, the phosphorylation of Ser2492 within the acidic-
cluster dileucine motif acts as a sorting signal for anterograde
transport by binding to GGA1 and GGA3 [23]. The GGA
proteins will transport the CI-M6PR by clathrin-coated pits to the
endosome. In the endosome the CI-M6PR will dissociate from
its ligand, which is subsequently transported to the lysosome.
On the endosome, the CI-M6PR co-localizes with the retromer
complex [4,6]. It is tempting to speculate that after binding of
mammalian Vps35 to the CI-M6PR in the endosome, Vps29
will dephosphorylate the receptor. Dephosphorylation of this
trafficking motif might be the trigger for the CI-M6PR to recycle
back to the TGN to carry out additional rounds of enzyme
delivery. This model remains to be confirmed by in vivo data
of dephosphorylation of the CI-M6PR by hVps29. In addition,
the exact role of dephosphorylation of the CI-M6PR in the
transport of the receptor remains to be investigated. Other proteins
that have been implicated in endosome-to-Golgi retrieval of the
cycling TGN proteins are TIP47 (47 kDa tail-interacting protein)
[49] and PACS-1 (phosphofurin cluster sorting protein-1) [50].
However, neither of these proteins is evolutionarily conserved
among eukaryotes and therefore may not be fundamental to
the eukaryote retrograde endosome-to-TGN vesicular transport
pathway.
In addition, it is interesting to note that Vps29 may function as a
phosphoesterase for other substrates as well. Mutational analysis
of the serine-phosphorylated peptide SFHDDpSDEDLLHI could
reveal a minimal sequence motif required for Vps29-dependent
dephosphorylation. In yeast, Vps35 not only binds the Vps10p
receptor, but also A-ALP (alkaline phosphatase) [11,51], so its
cytosolic tail DPAP A (dipeptidyl aminopeptidase A) is also
an interesting candidate for dephosphorylation by Vps29. Since
mammalian Vps35 is known to interact with the CI-M6PR
[4,6,9], it is tempting to speculate that Vps29 may be involved
in dephosphorylation of other acidic-cluster dileucine motifs as
well, many of which are regulated by serine phosphorylation like
the CD-M6PR (cation-dependent mannose 6-phosphate receptor)
and furin [52,53].
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